Sponsored By:

Pharma Stock May Be Just What the Doctor Ordered

The Medicines Company is trading in very bullish pattern supported by a stochastic buy

   

The Medicines Company (NASDAQ:MDCO) — This pharmaceutical company is focused on the treatment of critical care patients through the global hospital network. All of its acute-care, generic products are injectable. It recently entered into an agreement with AstraZeneca (NYSE:AZN) to market a key heart drug called Brilinta.

Analysts estimate that the company will earn 90 cents in 2012 and $1.26-plus in 2013.

Technically the stock broke from a right triangle in June, and then retreated to its uptrend line and 50-day moving average where it found support.

In July, it gapped higher as part of a bullish flag formation and recently popped from its 50-day moving average again. This is a very bullish pattern, and it supported by a buy from the stochastic. Our trading target for MDCO is $30-plus.

08 29 12 mdco 300x208 Pharma Stock May Be Just What the Doctor Ordered
Click to Enlarge

chart key 300x84 Pharma Stock May Be Just What the Doctor Ordered


Article printed from InvestorPlace Media, http://investorplace.com/2012/08/trade-of-the-day-the-medicines-company-nasdaq-mdco/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.